Abat.Bo
ABAT.BO operates in the Healthcare Facilities & Services industry, providing pharmaceutical products and related services.
Business. AMERICAN BATTERY TECHNOLOGY Co (ABAT) is a metals and mining company engaged in the production and sale of battery materials. The firm operates within the Basic Materials sector, specifically focusing on mineral resources. It is headquartered in the United States and is primarily listed on the Nasdaq stock exchange. The company does not disclose specific operating segments or geographic revenue breakdowns in the provided data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsFY 2026 earnings (expected)2026-08-09 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
AMERICAN BATTERY TECHNOLOGY Co (ABAT) is a metals and mining company engaged in the production and sale of battery materials. The firm operates within the Basic Materials sector, specifically focusing on mineral resources. It is headquartered in the United States and is primarily listed on the Nasdaq stock exchange. The company does not disclose specific operating segments or geographic revenue breakdowns in the provided data.
ABAT.BO maintains a conservative capital structure with a debt-to-equity ratio of 0.06, significantly below the industry median, indicating a low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.66, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its liquidity risk.
In terms of profitability, ABAT.BO's return on equity (ROE) is 0.0043 and return on assets (ROA) is 0.0035, both of which are below the industry median for Healthcare Facilities & Services. This suggests that the company is underperforming relative to its peers in generating returns for shareholders and utilizing its assets efficiently.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher operational and market risks if the segment faces challenges.
ABAT.BO's growth trajectory is not clearly defined in the available data, as there are no specific revenue growth projections or historical growth rates provided. The company's capital expenditure is minimal, with a negative value of -385,460 INR, indicating that it is not investing heavily in new projects or infrastructure.
The risk assessment for ABAT.BO highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. However, the dilution risk is low, as there is no indication of significant share issuance or dilution potential.
Recent events and filings for ABAT.BO are not detailed in the available data, making it difficult to assess any recent developments that could impact the company's financial performance or strategic direction.
- ABAT.BO has a conservative capital structure with a low debt-to-equity ratio of 0.06.
- The company's ROE and ROA are below the industry median, indicating underperformance in profitability.
- ABAT.BO's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company's liquidity risk is medium, and its dilution risk is low.
- ABAT.BO's growth trajectory is not clearly defined, and there is no significant capital expenditure.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director, Chief Executive Officer · Warrants → Common StockAcquired 2 367 656 @ $0,99purchase · 2026-06-05
- Chief Operating Officer · Warrants → Common StockAcquired 1 093 275 @ $1,07purchase · 2026-06-05
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ABAT.BO Market data — financials · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$28M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2025-12-310,00 %$25M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Funds · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- Director, Chief Executive Officer · Common StockOther 7 780 @ $2,50$19K · 2026-07-22
- Former Chief Resource Officer · Common StockOther 8 334 · 2026-07-20
- Director, Chief Executive Officer · Common StockOther 20 834 · 2026-07-20
- Director · Common StockOther 10 949 · 2026-07-06
- Director · Common StockOther 10 949 · 2026-07-06
- Director · Common StockOther 22 629 · 2026-07-06
- Director, Chief Executive Officer · Common StockOther 21 242 @ $2,88$61K · 2026-07-02
- Director, Chief Executive Officer · Common StockOther 24 695 @ $2,82$70K · 2026-07-01
- Director, Chief Executive Officer · Common StockOther 54 728 · 2026-07-01
- Former Chief Resource Officer · Common StockOther 21 569 · 2026-07-01
- Former Chief Resource Officer · Common StockOther 9 134 · 2026-06-30
- Director, Chief Executive Officer · Common StockOther 10 937 · 2026-06-30
- Director, Chief Executive Officer · Common StockOther 54 971 · 2026-06-30
- Chief Operating Officer · Common StockOther 55 680 @ $3,18$177K · 2026-06-17
- Chief Operating Officer · Common StockOther 102 598 · 2026-06-16
- Chief Operating Officer · Common StockSold 115 480 @ $3,56$411K · 2026-06-15
- Chief Operating Officer · Common StockOther 107 760 @ $3,49$376K · 2026-06-08
- Director, Chief Executive Officer · Common StockOther 138 270 @ $3,49$483K · 2026-06-08
- Chief Operating Officer · Common StockOther 203 700 · 2026-06-04
- Director, Chief Executive Officer · Common StockOther 337 955 · 2026-06-04
- Director, Chief Executive Officer · Common StockOther 9 323 @ $3,77$35K · 2026-06-02
- Director, Chief Executive Officer · Common StockOther 29 674 @ $0,71$21K · 2026-06-02
- Director, Chief Executive Officer · Common StockOther 33 384 · 2026-06-01
- Director, Chief Executive Officer · Common StockOther 4 962 @ $3,49$17K · 2026-04-22
- Former Chief Resource Officer · Common StockOther 8 333 · 2026-04-20
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -75.3%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 132.5%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 68.5%Derived (calculated)
- Current ratio (FY 2025-12-31): 14.88xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.04xDerived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 39.7%Derived (calculated)
- Shares outstanding (annual): 131.03MSEC XBRL filing
- Current liabilities (annual): USD 4.24MSEC XBRL filing
- Total assets (annual): USD 123.34MSEC XBRL filing
- Shareholders' equity (annual): USD 118.98MSEC XBRL filing
- Current assets (annual): USD 63.05MSEC XBRL filing
- Cash & equivalents (annual): USD 47.9MSEC XBRL filing
- Total liabilities (annual): USD 4.36MSEC XBRL filing
- Operating income (YoY) (2025-06-30 vs 2024-06-30): 12.0%Derived (calculated)
- Gross profit (YoY) (2025-06-30 vs 2024-06-30): -257.1%Derived (calculated)
- Operating cash flow (YoY) (2025-06-30 vs 2024-06-30): -72.7%Derived (calculated)
- Cost of revenue (YoY) (2025-06-30 vs 2024-06-30): 349.8%Derived (calculated)
- Net income (YoY) (2025-06-30 vs 2024-06-30): 10.9%Derived (calculated)
- EPS (basic) (YoY) (2025-06-30 vs 2024-06-30): 43.1%Derived (calculated)
- Revenue (YoY) (2025-06-30 vs 2024-06-30): 1,149.0%Derived (calculated)
- Gross margin (FY 2025-06-30): -246.5%Derived (calculated)
- Net margin (FY 2025-06-30): -1,090.0%Derived (calculated)
- EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): 43.1%Derived (calculated)
- R&D expense (YoY) (2025-06-30 vs 2024-06-30): -40.9%Derived (calculated)